Meridiem Investment Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
VCM
VPM
Meridiem Investment Management's LH Position: Q1 2026 in Review
Meridiem Investment Management reduced its Labcorp (LH) stake by 4.6% in Q1 2026, selling an estimated $12.9M and leaving 979,371 shares worth $261M. The position accounts for 6.67% of the portfolio, ranked #3.
Meridiem Investment Management first reported a position in LH in Q4 2020 and has held it in 22 quarters since. The position peaked at $304M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Meridiem Investment Management held 979,371 shares of Labcorp worth $261M as of Q1 2026.
- Meridiem Investment Management sold 47,523 Labcorp shares in Q1 2026, an estimated $12.9M.
- Labcorp made up 6.67% of Meridiem Investment Management's portfolio in Q1 2026, its #3 holding.
- Meridiem Investment Management first reported a position in Labcorp in Q4 2020 and has held it in 22 quarters since.
- Meridiem Investment Management's Labcorp position peaked at $304M in Q3 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Meridiem Investment Management's 13F filing for Q1 2026, filed 12 May 2026.